# Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

> **NCT04102943** · PHASE4 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 128 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** tacrolimus tablet
- **DRUG:** tacrolimus capsules

## Key facts

- **NCT ID:** NCT04102943
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2020-09-29
- **Final completion:** 2020-09-29
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04102943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04102943, "Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04102943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*